English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background  Femoral d P /d t  max  (maximum rate of the arterial pressure increase during systole) measured by pulse contour analysis has been proposed as a surrogate of left ventricular (LV) d P /d t  max  and as an estimator of LV systolic function. However, femoral d P /d t  max  may be influenced by LV loading conditions. In this study, we evaluated the impact of variations of LV systolic function, preload and afterload on femoral d P /d t  max  in critically ill patients with cardiovascular failure to ascertain its reliability as a marker of LV systolic function.    Results  We performed a prospective observational study to evaluate changes in femoral d P /d t  max , thermodilution-derived variables (PiCCO2—Pulsion Medical Systems, Feldkirchen, Germany) and LV ejection fraction (LVEF) measured by transthoracic echocardiography during variations in dobutamine and norepinephrine doses and during volume expansion (VE) and passive leg raising (PLR). Correlations with arterial pulse and systolic pressure, effective arterial elastance, total arterial compliance and LVEF were also evaluated. In absolute values, femoral d P /d t  max  deviated from baseline by 21% (201 ± 297 mmHg/s;  p  = 0.013) following variations in dobutamine dose ( n  = 17) and by 15% (177 ± 135 mmHg/s;  p  < 0.001) following norepinephrine dose changes ( n  = 29). Femoral d P /d t  max  remained unchanged after VE and PLR ( n  = 24). Changes in femoral d P /d t  max  were strongly correlated with changes in pulse pressure and systolic arterial pressure during dobutamine dose changes ( R  = 0.942 and 0.897, respectively), norepinephrine changes ( R  = 0.977 and 0.941, respectively) and VE or PLR ( R  = 0.924 and 0.897, respectively) ( p  < 0.05 in all cases). Changes in femoral d P /d t  max  were correlated with changes in LVEF ( R  = 0.527) during dobutamine dose variations but also with effective arterial elastance and total arterial compliance in the norepinephrine group ( R  = 0.638 and  R  = − 0.689) ( p  < 0.05 in all cases).    Conclusions  Pulse contour analysis-derived femoral d P /d t  max  was not only influenced by LV systolic function but also and prominently by LV afterload and arterial waveform characteristics in patients with acute cardiovascular failure. These results suggest that femoral d P /d t  max  calculated by pulse contour analysis is an unreliable estimate of LV systolic function during changes in LV afterload and arterial load by norepinephrine and directly linked to arterial waveform determinants.    Electronic supplementary material  The online version of this article (10.1186/s13613-019-0537-4) contains supplementary material, which is available to authorized users.

Influence of changes in ventricular systolic function and loading conditions on pulse contour analysis-derived femoral dP/dtmax